Adelaide Medical School
Faculty of Health and Medical Sciences
Dr Michael Cilento, MBBS, FRACP, is a medical oncologist and clinical research fellow at the Queen Elizabeth Hospital/Bragg Comprehensive Cancer Centre. He is currently a PhD candidate in the Prostate Cancer Research Group at the South Australian Health and Medical Research Institute (SAHMRI) led by Professor Lisa Butler. He completed his oncology training in South Australia, which was followed by a fellowship in early drug development at the Peter MacCallum Cancer Centre Melbourne and the centre for Biostatistics and Clinical Trials. Michael’s research is aimed at using multiomics to identify novel metabolic drivers of lethal prostate cancer.
Dr Cilento is supported by a RACP Fellows Research Entry Scholarship from the RACP Foundation.
Year Citation 2022 Cilento, M. A., Klein, O., Egan, E., & Roberts-Thomson, R. (2022). Talimogene laherparepvec resulting in near-complete response in a patient with treatment-refractory Merkel cell carcinoma. Australasian Journal of Dermatology, 63(3), e222-e225.
DOI Scopus1 WoS1 Europe PMC1
2022 Cilento, M. A., Kim, C., Chang, S., Farshid, G., & Brown, M. P. (2022). Three cases of BRAF-mutant melanoma with divergent differentiation masquerading as sarcoma. Pathologica, 114(3), 217-220.
2021 Cilento, M. A., & Hocking, C. M. (2021). Cystic and cavitating lung lesions as a presenting finding of metastatic prostate cancer. Medical Journal of Australia, 214(10), 459-459.e1.
2021 Cilento, M. A., Poplawski, N. K., Paramasivam, S., Thomas, D. M., & Kichenadasse, G. (2021). Germline PALB2 variants and PARP inhibitors in endometrial cancer. JNCCN Journal of the National Comprehensive Cancer Network, 19(11), 1212-1217.
DOI Scopus2 WoS2 Europe PMC2
Year Citation 2022 Cilento, M. A., Chalwin, R., Hocking, C., Chan, L., Smithers, L., & Joshi, R. (2022). MORBIDITY AND MORTALITY OF ONCOLOGY PATIENTS ADMITTED TO AN INTENSIVE CARE UNIT. In INTERNAL MEDICINE JOURNAL Vol. 52 (pp. 6). WILEY. 2021 Cilento, M., & Roberts-Thomson, R. (2021). Weight changes during adjuvant nivolumab for resected melanoma. In Poster Abstracts. Asia-Pacific Journal of Clinical Oncology, 17: 110-208.. Virtual.
Connect With Me